Can Fite Biofarma Ltd (CANF)
2.45
+0.07
(+2.94%)
USD |
NYAM |
May 23, 16:00
2.46
+0.01
(+0.41%)
After-Hours: 20:00
Can Fite Biofarma Cash from Financing (Quarterly)
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
Date | Value |
---|---|
December 31, 2013 | 5.972M |
September 30, 2013 | 0.1589M |
June 30, 2013 | 0.5139M |
March 31, 2013 | 6.570M |
December 31, 2012 | 0.0773M |
September 30, 2012 | 0.0003M |
Date | Value |
---|---|
June 30, 2012 | 1.390M |
March 31, 2012 | 0.0315M |
December 31, 2011 | 4.566M |
September 30, 2011 | 0.0133M |
June 30, 2011 | 0.0015M |
March 31, 2011 | 0.0642M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Financing (Quarterly) Benchmarks
Compugen Ltd | -- |
Pluri Inc | 0.00 |
BioLine Rx Ltd | 11.74M |
XTL Biopharmaceuticals Ltd | -- |
BiomX Inc | 38.98M |
Cash from Financing (Quarterly) Related Metrics
Free Cash Flow Yield | -82.79% |